Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.51
Last update: Dec 17, 4:00 PM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy NextCure (NXTC) stock?
You can purchase shares of NextCure (NASDAQ:NXTC) through any online brokerage.
Who are NextCure (NXTC) competitors?
Other companies in NextCure’s space includes: Skye Bioscience Inc (NASDAQ:SKYE), FibroGen Inc (NASDAQ:FGEN), Palatin Technologies Inc (AMEX:PTN), Vistagen Therapeutics Inc (NASDAQ:VTGN) and Fortress Biotech Inc (NASDAQ:FBIOP).
What is the forecast, or price target, for NextCure (NXTC) stock?
NextCure has a consensus price target of $10.00.
What is the current price for NextCure (NXTC)?
The stock price for NextCure (NASDAQ: NXTC) is $10.51 last updated December 17, 2025 at 4:00 PM EST.
Does NextCure (NXTC) pay a dividend?
There are no upcoming dividends for NextCure.
When is NextCure (NASDAQ:NXTC) reporting earnings?
NextCure does not have any upcoming earnings scheduled.
Is NextCure (NXTC) going to split?
There is no upcoming split for NextCure.
What sector and industry does NextCure (NXTC) operate in?
NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
